Kimberly-Clark to buy Tylenol maker Kenvue for over $40bn Kleenex maker Kimberly-Clark said today it will buy Tylenol parent Kenvue for more than $40 billion to create one of the biggest consumer health goods companies in the US. Business • 03 Nov
Kimberly-Clark to buy Tylenol maker Kenvue for over $40bn Kleenex maker Kimberly-Clark said today it will buy Tylenol parent Kenvue for more than $40 billion to create one of the biggest consumer health goods companies in the US. Business • 03 Nov
J&J forecasts 12.5% growth in 2023 profit Johnson & Johnson has today forecast 12.5% growth in its annual adjusted profit after completing the separation of consumer health company Kenvue. Business • 30 Aug 23
J&J forecasts 12.5% growth in 2023 profit Johnson & Johnson has today forecast 12.5% growth in its annual adjusted profit after completing the separation of consumer health company Kenvue. Business • 30 Aug 23
